Modulation by the noble gas argon of the catalytic and thrombolytic efficiency of tissue plasminogen activator

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 386, Issue 1, 2013, Pages 91-95

  David, Hélène N ^a   Haelewyn, Benoît ^b   Risso, Jean Jacques ^c   Abraini, Jacques H ^a,b  

^a UNIVERSITÉ LAVAL   (Canada)

^b UNIVERSITÉ DE CAEN   (France)

^c INSTITUT DE RECHERCHE BIOMÉDICALE DES ARMÉES   (France)

Author keywords

Acute ischemic stroke; Argon; Neuroprotection; Tissue plasminogen activator

Indexed keywords

ALTEPLASE; ARGON;

ANIMAL MODEL; ARTICLE; BLOOD CLOT LYSIS; BRAIN ISCHEMIA; CATALYSIS; MALE; NEUROPROTECTION; NONHUMAN; RAT; REPERFUSION INJURY;

ANIMALS; ARGON; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; FIBRINOLYTIC AGENTS; MALE; OXYGEN; RATS; RATS, SPRAGUE-DAWLEY; REPRODUCIBILITY OF RESULTS; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR;

EID: 84872317135     PISSN: 00281298     EISSN: 14321912     Source Type: Journal    
DOI: 10.1007/s00210-012-0809-0     Document Type: Article

References (30)

1. Abraini JH, Kriem B, Balon N, Rostain J-C, Risso J-J (2003) Gamma-aminobutyric neuropharmacological investigations on narcosis produced by nitrogen, argon, or nitrous oxide. Anesth Analg 96:746-749
2. Abraini JH, Lemaire M, David HN (2005) Potentially neuroprotective and therapeutic properties of nitrous oxide and xenon. Ann N Y Acad Sci 1053:289-300
3. Colloc'h N, Sopkova-de Oliveira Santos J, Retailleau P, Vivarès D, Bonneté F, Langlois d'Estaintot B, Gallois B, Brisson A, Risso J-J, Lemaire M, Prangé T, Abraini JH (2007) Protein crystallography under xenon and nitrous oxide pressure: comparison with in vivo pharmacology studies and implications for the mechanism of inhaled anesthetic action. Biophys J 92:217-224
4. Colloc'h N, Marassio G, Prangé T (2012) Protein-noble gas interactions investigated by crystallography on three enzymes - implication on anesthesia and neuroprotection mechanisms. In: Chandrasekaran A (ed) Current trends in X-ray crystallography. InTech Europe, Rijeka, pp 285-308
5. David HN, Leveillé F, Chazalviel L, MacKenzie ET, Buisson A, Lemaire M, Abraini JH (2003) Reduction of ischemic brain damade by nitrous oxide and xenon. J Cereb Blood Flow Metab 23:1168-1173
6. David HN, Haelewyn B, Rouillon C, Lecocq M, Chazalviel L, Apiou G, Risso J-J, Lemaire M, Abraini JH (2008) Neuroprotective effects of xenon: a therapeutic window of opportunity in rats subjected to transient cerebral ischemia. FASEB J 22:1275-1286
7. David HN, Haelewyn B, Risso J-J, Colloc'h N, Abraini JH (2010) Xenon is an inhibitor of tissue-plasminogen activator: adverse and beneficial effects in a rat model of thromboembolic stroke. J Cereb Blood Flow Metab 30:718-728
8. David HN, Haelewyn B, Degoulet M, Colomb DG Jr, Risso J-J, Abraini JH (2012a) Ex vivo and in vivo neuroprotection induced by argon when given after an excitotoxic or ischemic insult. PLoS One 7:e30934
9. David HN, Haelewyn B, Colomb DG Jr, Risso J-J, Abraini JH (2012b) Prothrombolytic action of normobaric oxygen given alone or in combination with recombinant tissue-plasminogen activator in a rat model of thromboembolic stroke. J Appl Physiol 12:2068-2076
10. Dingley J, Tooley J, Porter H, Thoresen M (2006) Xenon provides short-term neuroprotection in neonatal rats when administered after hypoxia-ischemia. Stroke 37:501-506
11. Dirnagl U, Iadecola C, Moskowitz MA (1999) Pathobiology of ischemic stroke: an integrated view. Trends Neurosci 22:391-397
12. Franks NP, Dickinson R, de Sousa SLM, Hall AC, Lieb WR (1998) How does xenon produce anesthesia? Nature 396:324
13. Haelewyn B, Chalzaviel L, Lecocq M, Risso J-J, Abraini JH (2011) Moderately delayed post-insult treatment with normobaric hyperoxia reduces excitotoxin-induced neuronal degeneration but increases ischemia-induced brain damage. Med Gas Res 1:2
14. Homi HM, Yokoo N, Warner DS, Franks NP, Maze M, Grocott HP (2003) The neuroprotective effect of xenon administration during transient middle cerebral artery occlusion in mice. Anesthesiology 99:876-881
15. Jawad N, Rizvi M, Gu J, Adeyi O, Tao G, Maze M, Ma D (2009) Neuroprotection (and lack of neuroprotection) afforded by a series of noble gases in an in vitro model of neuronal injury. Neurosci Lett 460:232-236
16. Lee JM, Zipfel GJ, Choi DW (1999) The changing landscape of ischemic brain injury mechanisms. Nature 399:A7-A14
17. Lo EH, Moskowitz MA, Jacobs TP (2005) Exciting, radical, suicidal: how brain cells die after stroke. Stroke 36:189-192
18. Loetscher PD, Rossaint J, Rossaint R, Weis J, Fries M, Fahlenkamp A, Ryang YM, Grottke O, Coburn M (2009) Argon: neuroprotection in in vitro models of cerebral ischemia and traumatic brain injury. Crit Care 13:R206
19. Ma D, Yang H, Lynch J, Franks NP, Maze M, Grocott HP (2003) Xenon attenuates cardiopulmonary bypass-induced neurologic and neurocognitive dysfunction in the rat. Anesthesiology 98:690-698
20. Ma D, Hossain M, Chow A, Arshad M, Battson RM, Sanders RD, Mehmet H, Edwards AD, Franks NP, Maze M (2005) Xenon and hypothermia combine to provide neuroprotection from neonatal asphyxia. Ann Neurol 58:182-193
21. Natale G, Cattano D, Abramo A, Forfori F, Fulceri F, Fornai F, Paparelli A, Giunta F (2006) Morphological evidence that xenon neuroprotects against N-methyl-DL-aspartic acid-induced damage in the rat arcuate nucleus: a time-dependent study. Ann N Y Acad Sci 1074:650-658
22. Pagel PS, Krolikowski JG, Shim YH, Venkatapuram S, Kersten JR, Weihrauch D, Warltier DC, Pratt PF (2007) Noble gases without anesthetic properties protect myocardium against infarction by activating prosurvival signalling kinases and inhibiting mitochondrial permeability transition in vivo. Anesth Analg 105:562-569
23. Pavlov BN, Grigoreiv AI, Smolin VV, Komordin IP, Sokolv GM, Ramazanov PS, Spirkov RR, Soldatov PE, Vdovin AV, Buravkova LB, Diachenko AI, Ilyin VK (1997) Investigations of different hyperoxic, hypoxic and normoxic oxygen-argon gaseous mixtures under different barometric pressure and respiration period. In: Bennett PB, Demchenko I, Marquis RE (eds) High pressure biology and medicine. University of Rochester Press, New York, pp 133-142
24. Petzelt C, Blom P, Schmehl W, Muller J, Kox WJ (2003) Prevention of neurotoxicity in hypoxic cortical neurons by the noble gas xenon. Life Sci 72:1909-1918
25. Ryang YM, Fahlenkamp AV, Rossaint R, Loetscher PD, Beyer C, Coburn M (2011) Neuroprotective effect of argon in an in vivo model of transient middle cerebral artery occlusion in rats. Crit Care Med 39:1448-1453
26. Semenov N (1986) How I can go to idea. Short moment of triumph. Nauka, Moscow, pp 6-19
27. Wilhelm E, Battino R (1973) Thermodynamic functions of the solubilities of gases in liquids at 25 C. Chem Rev 73:1-9
28. Yamakura T, Harris RA (2000) Effects of gaseous anesthetics nitrous oxide and xenon on ligand-gated ion channels. Comparison with isoflurane and ethanol. Anesthesiology 93:1095-10101
29. Yarin YM, Amarjargal N, Fuchs J, Haupt H, Mazurel B, Morozovan SV, Gross J (2005) Argon protects hypoxia-, cisplatin- and gentamycin-exposed hair cells in the newborn rat's organ of Corti. Hear Res 201:1-9
30. Zhuang L, Yang Tm Zhao H, Fidalgo AR, Vizcaychipi MP, Sanders RD, Yu B, Takata M, Johnson MR, Ma D (2012) The protective profile of argon, helium, and xenon in a model of neonatal asphyxia in rats. Crit Care Med 40:1724-1730